N
The startup develops a liver-targeting technology that effectively bypasses resistance mechanisms in cancer cells to treat liver diseases. This approach provides healthcare professionals with a reliable method to combat both cancer and viral infections affecting the liver.
San Diego, United States
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops a liver-targeting technology that effectively bypasses resistance mechanisms in cancer cells to treat liver diseases. This approach provides healthcare professionals with a reliable method to combat both cancer and viral infections affecting the liver.